Beijing Foyou Pharma CO.,LTD
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference f06f058723
Drug names87First applicant · distinct drug namesAcceptance records128First applicant · distinct acceptance numbersUnder-review numbers24First applicant · current under-review listCo-applicant records1Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
128 acceptance records as first applicant, grouped into 87 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 1 records · Latest accepted 2026/10/15
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2601287 | New drug | 2026/10/15 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/10/12
Generic · 2
Mirogabalin Besilate Tablets 2 records · Latest accepted 2026/09/03
Generic · 2
No verified English name 3 records · Latest accepted 2026/07/28
New drug · 2Supplement · 1
Ilaprazole Enteric-coated Tablets 2 records · Latest accepted 2026/07/14
Generic · 2
Halcinonide Topical Solution 1 records · Latest accepted 2026/07/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601278 | Supplement | 2026/07/07 | Beijing Foyou Pharma CO.,LTD; Fu Yuan Pharma Co., Ltd. romanized | CDE ↗ |
Mupirocin Ointment 1 records · Latest accepted 2026/07/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601279 | Supplement | 2026/07/07 | Beijing Foyou Pharma CO.,LTD; Fu Yuan Pharma Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/04/27
Generic · 2
Ketoprofen Patches 4 records · Latest accepted 2026/04/21
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600915 | Generic | 2026/04/21 | Beijing Foyou Pharma CO.,LTD; Fu Yuan Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2600914 | Generic | 2026/04/21 | Beijing Foyou Pharma CO.,LTD; Fu Yuan Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2500071 | Generic | 2025/03/26 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| CYHL2500070 | Generic | 2025/03/26 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Lansoprazole Enteric Capsules 4 records · Latest accepted 2026/04/01
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600661 | Supplement | 2026/04/01 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| CYHB2600660 | Supplement | 2026/04/01 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| CYHS2401264 | Generic | 2024/04/26 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| CYHS2401263 | Generic | 2024/04/26 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Levothyroxine Sodium Tablets 3 records · Latest accepted 2026/03/31
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600628 | Supplement | 2026/03/31 | Beijing Foyou Pharma CO.,LTD; Zhejiang Ai Sheng Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2400925 | Generic | 2024/03/27 | Beijing Foyou Pharma CO.,LTD; Zhejiang Ai Sheng Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2400924 | Generic | 2024/03/27 | Beijing Foyou Pharma CO.,LTD; Zhejiang Ai Sheng Pharma Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/03/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600717 | Generic | 2026/03/26 | Beijing Foyou Pharma CO.,LTD; Jilin Zhen Ao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Bedaquiline Fumarate Tablets 2 records · Latest accepted 2026/02/13
Supplement · 2
Baricitinib Tablets 1 records · Latest accepted 2026/01/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600012 | Generic | 2026/01/05 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Probucol Tablets 1 records · Latest accepted 2026/01/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600014 | Generic | 2026/01/05 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/12/31
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2501517 | New drug | 2025/12/31 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Cilnidipine Tablets 1 records · Latest accepted 2025/12/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504509 | Generic | 2025/12/31 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Mesalazine Enteric-coated Tablets 2 records · Latest accepted 2025/11/27
Supplement · 1Generic · 1
Ruxolitinib Phosphate Tablets 1 records · Latest accepted 2025/11/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504053 | Generic | 2025/11/25 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Folic Acid Tablets 2 records · Latest accepted 2025/11/24
Generic · 2
Paracetamol and Ibuprofen Tablets 1 records · Latest accepted 2025/10/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503740 | Generic | 2025/10/21 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Lacidipine Tablets 1 records · Latest accepted 2025/09/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503503 | Generic | 2025/09/24 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Clotrimazole Vaginal Tablets 2 records · Latest accepted 2025/09/05
Generic · 2
Linagliptin and Metformin Hydrochloride Extended Release Tablets 2 records · Latest accepted 2025/07/11
Generic · 2
Posaconazole Oral Suspension 1 records · Latest accepted 2025/07/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502390 | Generic | 2025/07/05 | Beijing Foyou Pharma CO.,LTD; Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Pemafibrate Tablets 1 records · Latest accepted 2025/06/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502259 | Generic | 2025/06/24 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Upadacitinib Sustained-release Tablets 1 records · Latest accepted 2025/04/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501433 | Generic | 2025/04/15 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Rotigotine Patches 1 records · Latest accepted 2025/04/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501325 | Generic | 2025/04/08 | Beijing Foyou Pharma CO.,LTD; Beijing Ya Bao Bio Pharma Co., Ltd. romanized | CDE ↗ |
Risedronate Sodium Tablets 1 records · Latest accepted 2025/01/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500475 | Generic | 2025/01/24 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/01/21
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500100 | New drug | 2025/01/21 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500151 | Generic | 2025/01/09 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Brexpiprazole Orally Disintegrating Tablets 2 records · Latest accepted 2025/01/08
Generic · 2
Thiamazole Tablets 2 records · Latest accepted 2025/01/08
Generic · 2
Benzbromarone Tablets 1 records · Latest accepted 2024/12/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404558 | Generic | 2024/12/27 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Pinaverium Bromide Tablets 2 records · Latest accepted 2024/12/19
Supplement · 2
No verified English name 2 records · Latest accepted 2024/12/12
Generic · 2
Clopidogrel Bisulfate and Aspirin Tablets 1 records · Latest accepted 2024/11/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403984 | Generic | 2024/11/21 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Crisaborole Ointment 1 records · Latest accepted 2024/11/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403848 | Generic | 2024/11/11 | Beijing Foyou Pharma CO.,LTD; Fu Yuan Pharma Co., Ltd. romanized | CDE ↗ |
Iguratimod Tablets 1 records · Latest accepted 2024/10/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403598 | Generic | 2024/10/24 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Olmesartan Medoxomil Orally Disintegrating Tablets 2 records · Latest accepted 2024/10/23
Generic · 2
Mesalazine Gastro-Resistant Prolonged-Release Granules 2 records · Latest accepted 2024/10/16
Generic · 2
Bromocriptine Mesilate Tablets 1 records · Latest accepted 2024/10/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403417 | Generic | 2024/10/12 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/09/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403323 | Generic | 2024/09/30 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Gliquidone Tablets 1 records · Latest accepted 2024/09/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403205 | Generic | 2024/09/25 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Trazodone Hydrochloride Tablets 1 records · Latest accepted 2024/09/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403009 | Generic | 2024/09/11 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Pioglitazone and Metformin Hydrochloride Tablets 2 records · Latest accepted 2024/08/08
Generic · 2
No verified English name 1 records · Latest accepted 2024/07/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402422 | Generic | 2024/07/31 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 2 records · Latest accepted 2024/07/16
Supplement · 1Generic · 1
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 2 records · Latest accepted 2024/07/16
Supplement · 1Generic · 1
Diclofenac Sodium Dual Release Enteric-coated Capsules 1 records · Latest accepted 2024/07/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402163 | Generic | 2024/07/12 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Candesartan Cilexetil and Hydrochlorothiazide Tablets 1 records · Latest accepted 2024/05/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401435 | Generic | 2024/05/13 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Benidipine Hydrochloride Tablets 2 records · Latest accepted 2024/04/29
Generic · 2
Loxoprofen Sodium Patches 2 records · Latest accepted 2024/04/25
Generic · 2
Acipimox Capsules 1 records · Latest accepted 2024/04/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401004 | Generic | 2024/04/03 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Arotinolol Hydrochloride Tablets 1 records · Latest accepted 2024/03/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400921 | Generic | 2024/03/27 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Amlodipine Besylate and Benazepril Hydrochloride Capsules 1 records · Latest accepted 2024/03/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400884 | Generic | 2024/03/21 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2024/02/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400698 | Generic | 2024/02/26 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/02/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400519 | Generic | 2024/02/06 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/12/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303532 | Generic | 2023/12/20 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Esomeprazole Magnesium for Delayed-release Oral Suspension 4 records · Latest accepted 2023/11/10
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302461 | Supplement | 2023/11/10 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2302460 | Supplement | 2023/11/10 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2302220 | Supplement | 2023/10/09 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
| CYHB2302219 | Supplement | 2023/10/09 | Beijing Foyou Pharma CO.,LTD; Chengdu Easton Biopharmaceuticals Co.,Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/10/31
Generic · 2
Rupatadine Fumarate Tablets 1 records · Latest accepted 2023/10/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302738 | Generic | 2023/10/13 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2023/10/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302741 | Generic | 2023/10/13 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/10/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302742 | Generic | 2023/10/13 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Telmisartan Tablets 2 records · Latest accepted 2023/08/30
Supplement · 2
Mesalamine extended release capsules 1 records · Latest accepted 2023/08/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302305 | Generic | 2023/08/30 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Dapagliflozin Tablets 1 records · Latest accepted 2023/08/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301776 | Supplement | 2023/08/11 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Pravastatin Sodium Tablets 2 records · Latest accepted 2023/07/26
Generic · 2
No verified English name 1 records · Latest accepted 2023/05/30
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301446 | Generic | 2023/05/30 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Agomelatine Tablets 1 records · Latest accepted 2023/05/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301340 | Generic | 2023/05/17 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Nicergoline Tablets 1 records · Latest accepted 2023/04/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301063 | Generic | 2023/04/17 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Ferrous Succinate Tablets 1 records · Latest accepted 2023/04/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301006 | Generic | 2023/04/10 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2023/03/18
Generic · 2
Levodopa and Benserazide Hydrochloride Tablets 1 records · Latest accepted 2023/03/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300742 | Generic | 2023/03/08 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Telmisartan and Hydrochlorothiazide Tablets 2 records · Latest accepted 2023/01/20
Generic · 2
Alendronate Sodium Tablets 1 records · Latest accepted 2022/09/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250610 | Supplement | 2022/09/29 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Cilostazol Tablets 1 records · Latest accepted 2022/09/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201576 | Generic | 2022/09/21 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Ezetimibe and Simvastatin Tablets 1 records · Latest accepted 2022/09/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201489 | Generic | 2022/09/08 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Fluvastatin Sodium Extended Release Tablets 1 records · Latest accepted 2022/08/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201272 | Generic | 2022/08/10 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Sitagliptin Phosphate Tablets 1 records · Latest accepted 2022/05/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200697 | Generic | 2022/05/05 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Compound α-Ketoacid Tablets 1 records · Latest accepted 2021/10/19
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150922 | Supplement | 2021/10/19 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets 2 records · Latest accepted 2021/05/27
Generic · 2
Repaglinide Tablets 2 records · Latest accepted 2021/04/14
Supplement · 2
Tedizolid Phosphate Tablets 1 records · Latest accepted 2021/04/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101047 | Generic | 2021/04/10 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Saxagliptin Tablets 2 records · Latest accepted 2021/03/22
Generic · 2
Losartan Potassium and Hydrochlorothiazide Tablets 1 records · Latest accepted 2021/01/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2100082 | Supplement | 2021/01/14 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
No verified English name 1 records · Latest accepted 2018/12/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS1800488 | Generic | 2018/12/18 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Changes in the last 90 days
8 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Marketing application approved: 2 applicationsAccepted: 5 applicationsNo longer listed under review: 1 application
- 2026/11/06No longer listed under review
Pemafibrate Tablets
CYHS2502259
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2025/06/24
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/03Marketing application approved
Upadacitinib Sustained-release Tablets
CYHS2501433 · 国药准字H20266511
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
View source · Table row 51 ↗ - 2026/10/20Marketing application approved
Rotigotine Patches
CYHS2501325 · 国药准字H20266348
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
View source · Table row 49 ↗ - 2026/10/15Accepted
No verified English name
CXHL2601287
Fact date: 2026/10/15 · Site observation date: 2026/10/22
View source ↗ - 2026/10/12Accepted
No verified English name
CYHL2600113
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ - 2026/10/12Accepted
No verified English name
CYHL2600112
Fact date: 2026/10/12 · Site observation date: 2026/10/22
View source ↗ - 2026/09/03Accepted
Mirogabalin Besilate Tablets
CYHS2602195
Fact date: 2026/09/03 · Site observation date: 2026/10/22
View source ↗ - 2026/09/03Accepted
Mirogabalin Besilate Tablets
CYHS2602194
Fact date: 2026/09/03 · Site observation date: 2026/10/22
View source ↗
Under review
24 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | CXHL2601287 | New drug | 2026/10/15 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| No verified English name | CYHL2600113 | Generic | 2026/10/12 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| No verified English name | CYHL2600112 | Generic | 2026/10/12 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Mirogabalin Besilate Tablets | CYHS2602195 | Generic | 2026/09/03 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Mirogabalin Besilate Tablets | CYHS2602194 | Generic | 2026/09/03 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| No verified English name | CXHS2600111 | New drug | 2026/07/28 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Ilaprazole Enteric-coated Tablets | CYHS2601671 | Generic | 2026/07/14 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| No verified English name | CYHS2600985 | Generic | 2026/04/27 | Beijing Foyou Pharma CO.,LTD; Anhui Sheng Shuang Ke Pharma Co., Ltd. romanized | CDE ↗ |
| Ketoprofen Patches | CYHS2600915 | Generic | 2026/04/21 | Beijing Foyou Pharma CO.,LTD; Fu Yuan Pharma Co., Ltd. romanized | CDE ↗ |
| Ketoprofen Patches | CYHS2600914 | Generic | 2026/04/21 | Beijing Foyou Pharma CO.,LTD; Fu Yuan Pharma Co., Ltd. romanized | CDE ↗ |
| No verified English name | CYHS2600717 | Generic | 2026/03/26 | Beijing Foyou Pharma CO.,LTD; Jilin Zhen Ao Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Bedaquiline Fumarate Tablets | CYHB2600350 | Supplement | 2026/02/13 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Probucol Tablets | CYHS2600014 | Generic | 2026/01/05 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Baricitinib Tablets | CYHS2600012 | Generic | 2026/01/05 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Cilnidipine Tablets | CYHS2504509 | Generic | 2025/12/31 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2504053 | Generic | 2025/11/25 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Folic Acid Tablets | CYHS2504043 | Generic | 2025/11/24 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Paracetamol and Ibuprofen Tablets | CYHS2503740 | Generic | 2025/10/21 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Lacidipine Tablets | CYHS2503503 | Generic | 2025/09/24 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Clotrimazole Vaginal Tablets | CYHS2503300 | Generic | 2025/09/05 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Linagliptin and Metformin Hydrochloride Extended Release Tablets | CYHS2502482 | Generic | 2025/07/11 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Linagliptin and Metformin Hydrochloride Extended Release Tablets | CYHS2502481 | Generic | 2025/07/11 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
| Posaconazole Oral Suspension | CYHS2502390 | Generic | 2025/07/05 | Beijing Foyou Pharma CO.,LTD; Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | CYHS1800488 | Generic | 2018/12/18 | Beijing Foyou Pharma CO.,LTD | CDE ↗ |
Catalogue holder records
89 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20265629 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bromocriptine Mesilate Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20265621 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20265630 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Orally Disintegrating Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20265551 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Orally Disintegrating Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20265550 | 2026/08/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levothyroxine Sodium Tablets | Beijing Foyou Pharma CO.,LTD | Zhejiang Ai Sheng Pharma Co., Ltd. romanized | 国药准字H20269149 | 2026/06/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pinaverium Bromide Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20133036 | 2026/06/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Benzbromarone Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20264774 | 2026/06/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thiamazole Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20264531 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thiamazole Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20264532 | 2026/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clopidogrel Bisulfate and Aspirin Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20264350 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil Orally Disintegrating Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20264147 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil Orally Disintegrating Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20264148 | 2026/04/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263986 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263935 | 2026/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gliquidone Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263825 | 2026/04/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263783 | 2026/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Iguratimod Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263757 | 2026/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Diclofenac Sodium Dual Release Enteric-coated Capsules | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263579 | 2026/03/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trazodone Hydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20263075 | 2026/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20255884 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20255574 | 2025/09/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Arotinolol Hydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20255323 | 2025/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amlodipine Besylate and Benazepril Hydrochloride Capsules | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20255200 | 2025/08/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levothyroxine Sodium Tablets | Beijing Foyou Pharma CO.,LTD | Zhejiang Ai Sheng Pharma Co., Ltd. romanized | 国药准字H20255126 | 2025/08/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lansoprazole Enteric Capsules | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20254990 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lansoprazole Enteric Capsules | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20254989 | 2025/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Benidipine Hydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20254764 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Benidipine Hydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20254631 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bisoprolol Fumarate and Amlodipine Besylate Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20254602 | 2025/06/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acipimox Capsules | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20254442 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20253967 | 2025/04/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20253380 | 2025/02/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20253160 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20253200 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20253115 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20253116 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20249598 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rupatadine Fumarate Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20249437 | 2024/11/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pravastatin Sodium Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244910 | 2024/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pravastatin Sodium Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244911 | 2024/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mesalazine Enteric-coated Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244953 | 2024/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ferrous Succinate Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244789 | 2024/09/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244732 | 2024/08/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244706 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nicergoline Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244710 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azilsartan Medoxomil Potassium Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244707 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Agomelatine Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20244560 | 2024/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levodopa and Benserazide Hydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20243955 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Telmisartan and Hydrochlorothiazide Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20243344 | 2024/03/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ezetimibe and Simvastatin Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20243231 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cilostazol Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20243197 | 2024/02/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fluvastatin Sodium Extended Release Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20234643 | 2023/12/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sitagliptin Phosphate Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20234332 | 2023/10/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Telmisartan and Hydrochlorothiazide Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20234226 | 2023/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alendronate Sodium Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20059029 | 2023/09/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20233540 | 2023/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20233541 | 2023/05/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20223933 | 2022/12/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Compound α-Ketoacid Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20093176 | 2022/11/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20223666 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20223667 | 2022/09/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20223497 | 2022/07/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20223498 | 2022/07/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bedaquiline Fumarate Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20213922 | 2021/12/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20213836 | 2021/10/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ezetimibe Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20213584 | 2021/07/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Venlafaxine Hydrochloride Sustained-Release Capsules | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20143052 | 2021/02/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ticagrelor Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20213086 | 2021/01/30 | Not stated by source | CDE ↗ |
| Celecoxib Capsules | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20213033 | 2021/01/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Repaglinide Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20133037 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Repaglinide Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20133017 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Telmisartan Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20060442 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Telmisartan Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20050996 | 2020/09/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olmesartan Medoxomil and Hydrochlorothiazide Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203469 | 2020/09/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Losartan Potassium and Hydrochlorothiazide Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20074021 | 2020/09/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Montelukast Sodium Chewable Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203382 | 2020/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Montelukast Sodium Chewable Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203381 | 2020/07/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gliclazide Modified Release Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20066231 | 2020/05/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Trimetazidine Dihydrochloride Modified Release Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203132 | 2020/03/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atorvastatin Calcium Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203100 | 2020/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atorvastatin Calcium Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203099 | 2020/03/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20203080 | 2020/03/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Moxifloxacin Hydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20183096 | 2019/12/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Acarbose Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20193360 | 2019/12/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trimetazidine Dihydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20065167 | 2019/12/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Paroxetine Hydrochloride Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20133084 | 2019/09/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olmesartan Medoxomil Tablets | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20061312 | 2019/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Beijing Foyou Pharma CO.,LTD | 国药准字H20255366 | 2025/09/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
44 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20260000784 | I | 2026/09/10 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20260000623 | I | 2026/07/17 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20260000360 | I | 2026/04/30 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20250000856 | I | 2025/08/18 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20240001452 | A | 2026/04/22 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20240001010 | A | 2026/02/28 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20240000682 | A | 2025/10/22 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20240000257 | A | 2025/12/20 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20240000126 | A | 2026/01/12 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20230000752 | A | 2024/12/13 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20230000674 | A | 2024/12/20 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20230000434 | A | 2026/02/10 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20230000085 | A | 2024/06/07 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20220001239 | A | 2026/05/20 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20220000410 | A | 2023/11/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20210001299 | A | 2023/11/20 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20210001246 | A | 2023/07/09 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20200001492 | A | 2022/10/28 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20200001502 | A | 2023/01/06 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20200000316 | A | 2025/12/27 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20200000298 | A | 2026/05/15 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20200000228 | A | 2026/05/15 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190008295 | A | 2023/11/23 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190008197 | A | 2025/09/11 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190007400 | A | 2023/11/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190007343 | A | 2023/08/12 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190007237 | A | 2026/05/20 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190007211 | A | 2023/05/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190007111 | A | 2023/03/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190006963 | A | 2023/03/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190006962 | A | 2023/03/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190006961 | A | 2023/03/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190006960 | A | 2023/03/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190006823 | A | 2023/03/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190006804 | A | 2023/03/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190005800 | A | — | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190005155 | A | — | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190003086 | A | 2025/01/18 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190003085 | A | 2025/01/18 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190001788 | A | 2024/10/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190001779 | A | 2024/09/26 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190001778 | A | 2024/08/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190000466 | A | 2025/09/24 | CDE ↗ |
| No verified English name | Beijing Foyou Pharma CO.,LTD | Y20190000257 | A | 2025/07/04 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
1 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JTH2300053 | Not stated by source | 2023/02/22 | CURIA ITALY SRL; Beijing Foyou Pharma CO.,LTD | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.